T0	KEYPHRASE-NOTYPES 4 11	patient
T1	KEYPHRASE-NOTYPES 20 35	treatment group
T2	KEYPHRASE-NOTYPES 40 58	objective evidence
T3	KEYPHRASE-NOTYPES 62 74	Lyme disease
T4	KEYPHRASE-NOTYPES 82 97	last evaluation
T5	KEYPHRASE-NOTYPES 105 114	treatment
T6	KEYPHRASE-NOTYPES 126 133	patient
T7	KEYPHRASE-NOTYPES 141 158	ceftriaxone group
T8	KEYPHRASE-NOTYPES 178 205	seventh-cranial-nerve palsy
T9	KEYPHRASE-NOTYPES 210 224	normal results
T10	KEYPHRASE-NOTYPES 228 243	lumbar puncture
T11	KEYPHRASE-NOTYPES 262 267	palsy
T12	KEYPHRASE-NOTYPES 275 296	three-month follow-up
T13	KEYPHRASE-NOTYPES 311 322	ceftriaxone
T14	KEYPHRASE-NOTYPES 346 351	weeks
T15	KEYPHRASE-NOTYPES 361 370	treatment
T16	KEYPHRASE-NOTYPES 376 381	palsy
T17	KEYPHRASE-NOTYPES 398 412	second patient
T18	KEYPHRASE-NOTYPES 414 435	large-joint arthritis
T19	KEYPHRASE-NOTYPES 453 462	treatment
T20	KEYPHRASE-NOTYPES 468 479	doxycycline
T21	KEYPHRASE-NOTYPES 486 493	patient
T22	KEYPHRASE-NOTYPES 503 510	fatigue
T23	KEYPHRASE-NOTYPES 528 538	limitation
T24	KEYPHRASE-NOTYPES 542 556	joint movement
T25	KEYPHRASE-NOTYPES 558 568	arthralgia
T26	KEYPHRASE-NOTYPES 574 581	myalgia
T27	KEYPHRASE-NOTYPES 608 631	intravenous ceftriaxone
T28	KEYPHRASE-NOTYPES 642 647	weeks
T29	KEYPHRASE-NOTYPES 658 677	complete resolution
T30	KEYPHRASE-NOTYPES 685 690	signs
T31	KEYPHRASE-NOTYPES 695 703	symptoms
